Dolcetti Riccardo (Orcid ID: 0000-0003-1625-9853) Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient. Francesca Caccuri 1 , Elena Muraro 2 , Annunziata Gloghini 3 , Ombretta Turriziani 4 , Mara Riminucci 4 , Cinzia Giagulli 1 , Katy Mastorci 2 , Damiana Antonia Fae’ 2 , Simona Fiorentini 1 , Antonino Carbone 5 , Arnaldo Caruso 1# , Riccardo Dolcetti 2,6*# . 1 Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 2 Immunopathology and Biomarker Unit, Department of Translational Research, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Italy. 3 Department of Pathology and Laboratory Medicine, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milano, Italy. 4 Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. 5 Department of Pathology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Italy. 6 University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia. # Shared senior authorship Running title: HIV p17 variant in splenic marginal zone lymphoma Keywords: marginal zone lymphoma, HIV, p17, B lymphocytes, lymphomagenesis Funding information: Associazione Italiana per la Ricerca sul Cancro; Grant numbers: 14287 (to R.D.) and 20108 (to A.Caru.) Word count: 3093 This article is protected by copyright. All rights reserved. This is the author manuscript accepted for publication and has undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/hon.2562